A Double-Blind, Randomized Study to Compare Onabutuliumtoxin A Versus Kenalog for Intravaginal Trigger Point Injections in the Treatment of Chronic Pelvic Pain
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Triamcinolone
- Indications Pelvic pain
- Focus Therapeutic Use
- 27 Mar 2018 Planned End Date changed from 1 May 2018 to 1 Jul 2018.
- 27 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Apr 2018.
- 27 Mar 2018 Status changed from recruiting to active, no longer recruiting.